Login to Your Account


SEC proposes rule to make Regulation A a viable route

By Mari Serebrov
Washington Editor

Thursday, December 19, 2013

Biotech start-ups may soon be able to travel a repaved Regulation A route to raise up to $50 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription